CD82 and breast carcinoma: It is interesting to note that Wang and colleagues [190] recently showed that exosomal tetraspanin CD82 was much more abundant in the serum of breast cancer (BC) patients than in healthy controls and that CD82 expression rose sharply as malignant breast cancer progressed.